IL6 and systemic sclerosis: In addition, the IL-6 mRNA and protein levels were significantly enhanced by combined treatment with NE and ET-1 compared to that achieved with treatment with NE or ET-1 alone (Fig. 4A,B), suggesting that the NE-induced IL-6 production in SSc fibroblasts is additively enhanced by simultaneous treatment with ET-1.